Logo ActuIA ActuIA

AI news from France

Français Español Italiano Deutsch Nederlands Română Polski Português العربية Türkçe Українська 中文 日本語 한국어
Publish
Home
AI Watch

By category

Funding Mergers & acquisitions Model release Product launch Partnership Public program / call for projects Regulation & governance Litigation Research & science Deployment & adoption Infrastructure & compute Corporate & strategy Security & incident Report & study Event

By sector

Company Culture Defense Education Finance Fundamental Research Health - medicine Industry Insurance Justice Marketing Media Risk Prevention Social networks Telecommunications Transport

By category

Funding Mergers & acquisitions Model release Product launch Partnership Public program / call for projects Regulation & governance Litigation Research & science Deployment & adoption Infrastructure & compute Corporate & strategy Security & incident Report & study Event

By sector

Company Culture Defense Education Finance Fundamental Research Health - medicine Industry Insurance Justice Marketing Media Risk Prevention Social networks Telecommunications Transport
Latest news
Language

Servier

Servier est un groupe pharmaceutique français. Fondé en 1954, il est présent dans 149 pays et compte près de 22 000 salariés. Juridiquement, le groupe Servier est gouverné par une Fondation néerlandaise sans capital et sans but lucratif. Elle a le pouvoir de nommer ou de révoquer les dirigeants du groupe.

3 articles liés à cet acteur

Paris-Saclay SPRING invites innovation leaders on May 20, 2025, at École Polytechnique

Paris-Saclay SPRING invites innovation leaders on May 20, 2025, at École Polytechnique

Paris-Saclay SPRING 2025 invites the leaders of Innovation made in Paris-Saclay to forge new economic and strategic ties.

Apr 18, 2025 Read more →
Aqemia raises €30 million to accelerate large-scale drug discovery

Aqemia raises €30 million to accelerate large-scale drug discovery

Aqemia announced on October 19 that it had raised €30 million in a Series A financing round co-led by Eurazeo and Bpifrance via its Large Venture fund...

Oct 21, 2022 Read more →
Servier and Oncodesign Precision Medecines collaborate to develop new treatments for pancreatic cancer

Servier and Oncodesign Precision Medecines collaborate to develop new treatments for pancreatic cancer

Servier, an international pharmaceutical company, and Oncodesign Precision Medicine (OPM), a subsidiary of the Oncodesign biopharmaceutical group, ann...

Sep 30, 2022 Read more →
Logo ActuIA Logo ActuIA

Your source of information on artificial intelligence and its advances.

Navigation

  • Legal notice
  • Contact

Follow us

© 2019-2026 Net Square Digital. All rights reserved.